Kazuhiko Kakihana

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

Journal: Blood advances
Published: May 12, 2026

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Journal: Blood advances
Published: January 13, 2026

Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Journal: Blood advances
Published: January 15, 2024

Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.

Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: May 19, 2022

Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.

Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.

Journal: Leukemia research
Published: April 04, 2021

Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia

Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 10, 2020

Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.

Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.

Journal: Bone marrow transplantation
Published: November 29, 2020

Successful Cord Blood Transplantation for Idiopathic CD4+ Lymphocytopenia.

Successful Cord Blood Transplantation for Idiopathic CD4+ Lymphocytopenia.

Journal: Acta haematologica
Published: November 21, 2020

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.

Journal: EClinicalMedicine
Published: June 30, 2020

Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation.

Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation.

Journal: Blood advances
Published: June 08, 2020

T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.

T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.

Journal: Scientific reports
Published: May 28, 2020

Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation.

Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 16, 2020
Showing 1-12 of 107

Last Updated: 09/26/2026